Myositis, Dermatomyositis research hub

A Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, and Efficacy of Empasiprubart in Adults With Dermatomyositis

This study is testing a new medicine, empasiprubart, for adults with a condition called dermatomyositis. It's looking at how safe the medicine is, if people can tolerate it, and if it helps improve their symptoms. Some people will get the new medicine, and others will get a dummy treatment (placebo).